The Unsung Heroes of Vaccine Development: Measuring T-Cell Immunity
When a vaccine is developed, its effectiveness is measured in two primary ways: the antibody response and the T-cell response. While antibodies are the first line of defense, T-cells provide a long-lasting, cellular memory that is crucial for sustained immunity. For decades, measuring this T-cell response was a major challenge for scientists. ELISpot and FluoroSpot assays have changed that. These tools allow researchers to accurately quantify the number of T-cells that are activated after vaccination, providing a clear picture of the strength and duration of the immune response. This data is essential for designing more effective vaccines and for understanding why some vaccines work better than others. In the race to develop new vaccines for infectious diseases, these assays are the unsung heroes, providing the critical data needed to make informed decisions. Their use in this field is a major driver of the ELISpot and FluoroSpot Assay Market.